Premium
Expression of Wnt‐1 and TSLC1 in condyloma acuminatum
Author(s) -
Yin G. W.,
Xia X. X.,
Song F. J.,
Huang Y. H.
Publication year - 2019
Publication title -
clinical and experimental dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.587
H-Index - 78
eISSN - 1365-2230
pISSN - 0307-6938
DOI - 10.1111/ced.13862
Subject(s) - foreskin , condyloma acuminatum , wnt signaling pathway , immunohistochemistry , medicine , malignant transformation , andrology , pathology , biology , gene , genetics , cell culture , human papillomavirus
Summary Background Despite its high contagiousness, high recurrence rate and potential for malignant transformation, effective treatments for condyloma acuminatum (CA) have not yet been developed. Accordingly, it is necessary to clarify the mechanisms underlying CA development. Aim To investigate the expression and significance of the proteins Wnt‐1 and TSLC1 in patients with CA and in normal foreskin controls. Methods Wnt‐1 and TSLC1 were assessed by immunohistochemistry in 45 patients with CA. Results Positive expression rates of Wnt‐1 and TSLC1 were 82.22% (37/45) and 37.78% (17/45), respectively, in CA tissues, and 29.17% (7/24) and 91.67% (22/24), respectively, in normal foreskin controls. Wnt‐1 expression intensity in CA was markedly higher (positive to strongly positive) than that in normal controls (negative to weakly positive), whereas TSLC1 expression intensity ranged from weakly positive to positive in CA, and nearly strongly positive in the normal control group. The differences in the positive expression rate and expression intensity of Wnt‐1 and TSLC1 between the two groups were statistically significant ( P < 0.05). In addition, Wnt‐1 and TSLC1 were negatively correlated. ( r = −0.336, P < 0.05). Conclusions Overexpression of Wnt‐1 and low expression of TSLC1 may be associated with the growth of CA. These findings may provide a basis for the development of therapies to prevent recurrence or malignant transformation of CA.